Drawing for OPUS MEDICAL

USPTO serial 79223757

OPUS MEDICAL

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
BLAZICH, JOAN MICHELE
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with OPUS MEDICAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Computer software and computer programs, namely, computer software and computer programs to provide feedback to patients to aid breathing and stability during medical imaging and radiation procedures in the fields of medical applications, medical apparatus, medical devices, and for medical purposes, excluding software and programs to be used in connection with laboratory test samples cards for microbiological testing and identificationABANDONED—
010Apparatus, equipment and devices for medical testing, namely, biofeedback monitors to provide feedback to patients to aid breathing and stability during medical imaging and radiation procedures; Apparatus, equipment and devices for medical diagnosis, namely, biofeedback monitors to provide feedback to patients to aid breathing and stability during medical imaging and radiation procedures; Medical apparatus and instruments, namely, biofeedback monitors to provide feedback to patients to aid breathing and stability during medical imaging and radiation procedures; Medical devices for monitoring vital signs of patients, namely, biofeedback monitors to provide feedback to patients to aid breathing and stability during medical imaging and radiation procedures; Medical analysis apparatus, equipment and devices, namely, biofeedback monitors to provide feedback to patients to aid breathing and stability during medical imaging and radiation procedures; Medical apparatus, equipment and devices for monitoring, namely, biofeedback monitors to provide feedback to patients to aid breathing and stability during medical imaging and radiation procedures; Medical apparatus, equipment and devices for measuring purposes, namely, biofeedback monitors to provide feedback to patients to aid breathing and stability during medical imaging and radiation procedures; Electronic apparatus and devices for medical treatment purposes, namely, biofeedback monitors to provide feedback to patients to aid breathing and stability during medical imaging and radiation procedures; Electronic monitoring apparatus for medical purposes, namely, biofeedback monitors to provide feedback to patients to aid breathing and stability during medical imaging and radiation procedures; Respiratory monitors for medical use, namely, biofeedback monitors to provide feedback to patients to aid breathing and stability during medical imaging and radiation procedures; Apparatus for use in medical analysis, namely, biofeedback monitors to provide feedback to patients to aid breathing and stability during medical imaging and radiation procedures; Analysing apparatus for medical use, namely, biofeedback monitors to provide feedback to patients to aid breathing and stability during medical imaging and radiation procedures; all the aforementioned goods excluding laboratory test samples cards for microbiological testing and identificationABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 13, 2022DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Mar 12, 2022DETHDEATH OF INTERNATIONAL REGISTRATION—
Mar 20, 2020FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 28, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 28, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 8, 2019LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Mar 1, 2019LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Feb 28, 2019MAB4ABANDONMENT NOTICE MAILED - INTER PARTES DECISION—
Feb 28, 2019ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Feb 28, 2019OP.TOPPOSITION TERMINATED NO. 999999—
Feb 28, 2019OP.SOPPOSITION SUSTAINED NO. 999999—
Feb 19, 2019LIMELIMITATION FROM THE IB EXAMINED AND ENTERED—
Feb 15, 2019LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Dec 15, 2018RFNTREFUSAL PROCESSED BY IB—
Nov 23, 2018OP.IOPPOSITION INSTITUTED NO. 999999—
Nov 16, 2018OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB—
Nov 16, 2018OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED—
Oct 16, 2018ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Oct 16, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 12, 2018GPNXNOTIFICATION PROCESSED BY IB—
Sep 26, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 26, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Sep 26, 2018NPUBNOTICE OF PUBLICATION—
Sep 13, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 11, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 11, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 6, 2018ALIEASSIGNED TO LIE—
Aug 22, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 9, 2018RFNTREFUSAL PROCESSED BY IB—
Feb 22, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 22, 2018RFRRREFUSAL PROCESSED BY MPU—
Feb 14, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 13, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 12, 2018DOCKASSIGNED TO EXAMINER—
Jan 6, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 2, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 28, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance